Literature DB >> 20410058

Near IR heptamethine cyanine dye-mediated cancer imaging.

Xiaojian Yang1, Chunmeng Shi, Rong Tong, Weiping Qian, Haiyen E Zhau, Ruoxiang Wang, Guodong Zhu, Jianjun Cheng, Vincent W Yang, Tianmin Cheng, Maged Henary, Lucjan Strekowski, Leland W K Chung.   

Abstract

PURPOSE: Near-IR fluorescence imaging has great potential for noninvasive in vivo imaging of tumors. In this study, we show the preferential uptake and retention of two hepatamethine cyanine dyes, IR-783 and MHI-148, in tumor cells and tissues. EXPERIMENTAL
DESIGN: IR-783 and MHI-148 were investigated for their ability to accumulate in human cancer cells, tumor xenografts, and spontaneous mouse tumors in transgenic animals. Time- and concentration-dependent dye uptake and retention in normal and cancer cells and tissues were compared, and subcellular localization of the dyes and mechanisms of the dye uptake and retention in tumor cells were evaluated using organelle-specific tracking dyes and bromosulfophthalein, a competitive inhibitor of organic anion transporting peptides. These dyes were used to detect human cancer metastases in a mouse model and differentiate cancer cells from normal cells in blood.
RESULTS: These near-IR hepatamethine cyanine dyes were retained in cancer cells but not normal cells, in tumor xenografts, and in spontaneous tumors in transgenic mice. They can be used to detect cancer metastasis and cancer cells in blood with a high degree of sensitivity. The dyes were found to concentrate in the mitochondria and lysosomes of cancer cells, probably through organic anion transporting peptides, because the dye uptake and retention in cancer cells can be blocked completely by bromosulfophthalein. These dyes, when injected to mice, did not cause systemic toxicity.
CONCLUSIONS: These two heptamethine cyanine dyes are promising imaging agents for human cancers and can be further exploited to improve cancer detection, prognosis, and treatment. Copyright (c) 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410058      PMCID: PMC2871283          DOI: 10.1158/1078-0432.CCR-10-0059

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  47 in total

1.  Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots.

Authors:  Xingyong Wu; Hongjian Liu; Jianquan Liu; Kari N Haley; Joseph A Treadway; J Peter Larson; Nianfeng Ge; Frank Peale; Marcel P Bruchez
Journal:  Nat Biotechnol       Date:  2002-12-02       Impact factor: 54.908

2.  Cyanine dyes as contrast agents in biomedical optical imaging.

Authors:  Kai Licha; Björn Riefke; Bemd Ebert; Carsten Grötzinger
Journal:  Acad Radiol       Date:  2002-08       Impact factor: 3.173

Review 3.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.

Authors:  Vasilis Ntziachristos; Christoph Bremer; Ralph Weissleder
Journal:  Eur Radiol       Date:  2002-07-19       Impact factor: 5.315

Review 4.  In vivo near-infrared fluorescence imaging.

Authors:  John V Frangioni
Journal:  Curr Opin Chem Biol       Date:  2003-10       Impact factor: 8.822

5.  The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.

Authors:  W Al Sarakbi; R Mokbel; M Salhab; W G Jiang; M J Reed; K Mokbel
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

Review 6.  Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies.

Authors:  M Maio; M Altomonte; L Calabro; E Fonsatti
Journal:  Front Biosci       Date:  2001-06-01

7.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

8.  Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.

Authors:  Y Cui; J König; I Leier; U Buchholz; D Keppler
Journal:  J Biol Chem       Date:  2000-12-27       Impact factor: 5.157

9.  LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

Authors:  G N Thalmann; R A Sikes; T T Wu; A Degeorges; S M Chang; M Ozen; S Pathak; L W Chung
Journal:  Prostate       Date:  2000-07-01       Impact factor: 4.104

10.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye.

Authors:  Aki Ito; Katsuhiro Yamaguchi; Hiroshi Tomita; Takehiro Suzuki; Tohru Onogawa; Takeaki Sato; Hiroya Mizutamari; Tsuyoshi Mikkaichi; Toshiyuki Nishio; Takashi Suzuki; Michiaki Unno; Hironobu Sasano; Takaaki Abe; Makoto Tamai
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

View more
  92 in total

1.  Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.

Authors:  Derek Reichel; Bien Sagong; James Teh; Yi Zhang; Shawn Wagner; Hongqiang Wang; Leland W K Chung; Pramod Butte; Keith L Black; John S Yu; J Manuel Perez
Journal:  ACS Nano       Date:  2020-06-23       Impact factor: 15.881

2.  A Near-IR Fluorescent Dasatinib Derivative That Localizes in Cancer Cells.

Authors:  Syed Muhammad Usama; Bosheng Zhao; Kevin Burgess
Journal:  Bioconjug Chem       Date:  2019-04-01       Impact factor: 4.774

3.  Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Changhong Shi; Qinlong Li; Peizhen Hu; Yi-Ting Chen; Xiaoliang Dou; Divya Sahu; Wei Li; Hiroshi Harada; Yi Zhang; Ruoxiang Wang; Haiyen E Zhau; Leland W K Chung
Journal:  Biomaterials       Date:  2014-06-21       Impact factor: 12.479

4.  Novel cancer-targeting SPECT/NIRF dual-modality imaging probe (99m)Tc-PC-1007: synthesis and biological evaluation.

Authors:  Yi Zhang; Li Xiao; Kosta Popovic; Xiuzhen Xie; Mahendra D Chordia; Leland W K Chung; Mark B Williams; Wei Yue; Dongfeng Pan
Journal:  Bioorg Med Chem Lett       Date:  2013-10-01       Impact factor: 2.823

5.  Cyanine-Gemcitabine Conjugates as Targeted Theranostic Agents for Glioblastoma Tumor Cells.

Authors:  Zhengyang Jiang; Kathryn Pflug; Syed Muhammad Usama; Dacheng Kuai; Xin Yan; Raquel Sitcheran; Kevin Burgess
Journal:  J Med Chem       Date:  2019-10-11       Impact factor: 7.446

6.  Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling.

Authors:  Swati Kushal; Brooke Bullock Lao; Laura K Henchey; Ramin Dubey; Hanah Mesallati; Nathaniel J Traaseth; Bogdan Z Olenyuk; Paramjit S Arora
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

7.  Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.

Authors:  Sean P Arlauckas; Anatoliy V Popov; Edward J Delikatny
Journal:  Mol Cancer Ther       Date:  2014-07-15       Impact factor: 6.261

Review 8.  Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.

Authors:  Aniv Mann; Inessa Semenenko; Michal Meir; Sara Eyal
Journal:  AAPS J       Date:  2015-03-31       Impact factor: 4.009

9.  Photothermal and photodynamic activity of polymeric nanoparticles based on α-tocopheryl succinate-RAFT block copolymers conjugated to IR-780.

Authors:  Raquel Palao-Suay; Francisco M Martín-Saavedra; María Rosa Aguilar; Clara Escudero-Duch; Sergio Martín-Saldaña; Francisco J Parra-Ruiz; Nathan A Rohner; Susan N Thomas; Nuria Vilaboa; Julio San Román
Journal:  Acta Biomater       Date:  2017-05-13       Impact factor: 8.947

10.  miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer.

Authors:  Sajni Josson; Murali Gururajan; Peizhen Hu; Chen Shao; GinaChia-Yi Chu; Haiyen E Zhau; Chunyan Liu; Kaiqin Lao; Chia-Lun Lu; Yi-Tsung Lu; Jake Lichterman; Srinivas Nandana; Quanlin Li; Andre Rogatko; Dror Berel; Edwin M Posadas; Ladan Fazli; Dhruv Sareen; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2014-06-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.